Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes Management and Research, Diabetes and associated disorders, Pancreatic function and diabetes, and Chronic Kidney Disease and Diabetes.
Which glomerular filtration rate estimation equations should be used in youth with type 1 diabetes?
Cerebral fuels within the first week of life in very preterm infants: a cohort study.
Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial
Metabolic disorders in young people around the world.
NICE guideline review: type 2 diabetes in children and young people - diagnosis and management (NG18).
Early Detection of β-Cell Decline Using Home Dried Blood Spot C-Peptide Levels in New-Onset Type 1 Diabetes.
Vascular Complications in Children and Young People with Type 1 Diabetes: A Worldwide Assessment of Diabetologists' Adherence to International Recommendations.
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Reply to Mallone R [letter].
Development and Methodology of the 2024 and 2026 ISPAD Clinical Practice Guidelines.
How to Safely Use Diluted Insulin in an Automated Insulin Delivery System in Very Young Children: An Educator Perspective.
Preventing and Managing Vascular Complications in Adolescents With Type 1 Diabetes.
Successful use of a fully closed-loop insulin delivery system in an adolescent with diabetes secondary to pancreatitis - a case report.
Little Loopers: A Case Series of Automated Insulin Delivery Usage with Standard and Diluted Insulin in Very Young Children with Diabetes Mellitus.
ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes.
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults
Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes.
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults.
Gut microbiome shifts in people with type 1 diabetes are associated with glycaemic control: an INNODIA study.
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes.
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes
A study to determine a capillary alternative to the gold standard oral glucose tolerance test - Protocol
Fifteen-minute consultation: Management of albuminuria in children and young people with diabetes.
A study to determine a capillary alternative to the gold standard oral glucose tolerance test - Protocol
A study to determine a capillary alternative to the gold standard oral glucose tolerance test - <i>Protocol</i>.
<scp>ISPAD</scp> Clinical Practice Consensus Guidelines 2022: Microvascular and macrovascular complications in children and adolescents with diabetes